Bulletin
Investor Alert

Corvus Pharmaceuticals Inc.

NAS: CRVS

GO
/marketstate/country/us

Market closed

/zigman2/quotes/208484371/composite

$

4.01

Change

+0.13 +3.35%

Volume

Volume 98,691

Sep 25, 2020, 4:00 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/208484371/composite

Previous close

$ 3.88

$ 4.01

Change

+0.13 +3.35%

Day low

Day high

$3.86

$4.14

Open
Open: 3.88

52 week low

52 week high

$1.01

$6.88

Open

Market cap

$112.42M

Average volume

379,819

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-1.55

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/crvs

MarketWatch News on CRVS

  1. Corvus Pharmaceuticals stock price target raised to $8 from $5 at Wedbush

    7:34 a.m. July 8, 2020

    - Tomi Kilgore

  2. Carl Icahn and Starboard Value Differ on Newell Brands

    8:00 p.m. March 23, 2018

    - Barron's Online

  3. Down With Teva, Up With Portola

    11:03 a.m. Aug. 25, 2017

    - Barron's Online

  4. In a Big Year for IPOs, Valuations Are a Concern

    2:51 a.m. July 8, 2017

    - Barron's Online

  5. Three Top Picks in Smaller Pharma

    11:54 a.m. May 2, 2017

    - Barron's Online

  6. Charting the Market

    12:29 a.m. April 8, 2017

    - Barron's Online

  7. When Gilead Sciences Speaks…

    1:09 p.m. Sept. 8, 2016

    - Barrons Blogs

  8. These 15 Biotech Companies Could Be Takeover Targets

    11:06 a.m. June 29, 2016

    - Barrons Blogs

  9. David Sokol Sizes Up Middleburg Financial

    12:05 a.m. April 9, 2016

    - Barron's Online

  10. IPOs: The Worst Yearly Start Since the Recession

    12:18 a.m. April 2, 2016

    - Barron's Online

  11. Corvus Pharmaceuticals opens at $15 in market debut, priced at $15

    10:35 a.m. March 23, 2016

    - Caitlin Huston

  12. Corvus Pharma sets IPO range at $15 to $17 a share

    6:55 p.m. March 10, 2016

    - Wallace Witkowski

Analyst Ratings

/news/nonmarketwatch/company/us/crvs

Other News on CRVS

  1. Corvus Pharma +10% on encouraging CPI-006 data in COVID-19

    9:18 a.m. Sept. 10, 2020

    - Seeking Alpha

  2. 10-Q: CORVUS PHARMACEUTICALS, INC.

    6:50 p.m. July 30, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  3. IPO Update: iTeos Therapeutics Finalizes IPO Plan

    1:31 p.m. July 21, 2020

    - Seeking Alpha

  4. NVAX, MFGP, RUN and TOPS among midday movers

    12:43 p.m. July 7, 2020

    - Seeking Alpha

  5. NVAX, LVGO among premarket gainers

    8:18 a.m. July 7, 2020

    - Seeking Alpha

  6. iTeos Therapeutics Begins U.S. IPO Rollout

    3:59 p.m. July 2, 2020

    - Seeking Alpha

  7. What Makes Corvus (CRVS) a New Buy Stock

    12:00 p.m. May 20, 2020

    - Zacks.com

  8. 10-Q: CORVUS PHARMACEUTICALS, INC.

    4:19 p.m. April 30, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  9. Jefferines likes United Therapeutics in premarket analyst action

    7:56 a.m. March 10, 2020

    - Seeking Alpha

  10. Jefferies likes United Therapeutics in premarket analyst action

    7:56 a.m. March 10, 2020

    - Seeking Alpha

  11. 10-K: CORVUS PHARMACEUTICALS, INC.

    4:14 p.m. March 9, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  12. Eyes On Coronavirus, Alibaba, Samsung And Overstock.com

    9:38 a.m. Feb. 8, 2020

    - Seeking Alpha

  13. Key events next week - healthcare

    10:47 a.m. Feb. 7, 2020

    - Seeking Alpha

  14. Loading more headlines...
/news/pressrelease/company/us/crvs

Press Releases on CRVS

  1. Corvus Announces Participation in Upcoming Investor Conferences

    6:02 p.m. Sept. 8, 2020

    - GlobeNewswire

  2. Corvus Announces Participation in Upcoming Investor Conferences

    6:02 p.m. Sept. 8, 2020

    - GlobeNewswire

  3. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.